Wuhan Zhongke Optics Valley Green Biotechnology Co.,Ltd. (CASOV) founded in 2010, operates in the biotechnology industry, with headquarters in China. The company focuses on microbial fermentation technology and product R&D, production, sales, and technical services, situated in Wuhan East Lake Hightech Development Zone "Biolake". It is also the operational management entity of Biotechnology Engineerization Center of Hubei Incubation Center of CAS. CASOV's core mission is "innovation, dedication, service, and win-win", driven by the value of unification across customers, employees, shareholders, society, and government. The company's offerings include Neu5Ac, Astaxanthin, ARA, DHA, emphasizing collaboration with enterprises in pharmaceuticals, cosmetics, functional food, and trading.
The latest development for CASOV is a CNY10.65M Venture Round investment received on 29 January 2021 from Cabio, showcasing investor confidence in the company's pursuits within the biotechnology sector and its commitment to innovation and service. The investment presents opportunities for expansion and advancing its existing product portfolio, potentially amplifying its impact in the market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | CNY10.65M | 1 | Cabio | 29 Jan 2021 |
No recent news or press coverage available for Wuhan Zhongke Optics Valley Green Biotechnology Co.,Ltd.
We care about your data, and we'd love to use cookies make your experience better.